Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
Naoi H, Suzuki Y, Mori K, Aono Y, Kono M, Hasegawa H, Yokomura K, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T.
Naoi H, et al. Among authors: yokomura k.
Thorax. 2022 Jul;77(7):727-730. doi: 10.1136/thoraxjnl-2021-218281. Epub 2022 Mar 30.
Thorax. 2022.
PMID: 35354649